Literature DB >> 15731180

Ontogeny of CD4+CD25+ regulatory/suppressor T cells in human fetuses.

Guillaume Darrasse-Jèze1, Gilles Marodon, Benoît L Salomon, Martin Catala, David Klatzmann.   

Abstract

Little is known about the ontogeny of naturally occurring CD4(+)CD25(+) regulatory/suppressor T cells that play a major role in maintaining self-tolerance in mice and humans. In rodents, thymectomy on day 3 of life leads to multiple organ-specific autoimmune diseases that can be prevented by adoptive transfer of regulatory T cells, suggesting their neonatal development. We investigated regulatory T-cell ontogeny in 11 human fetuses. Together with the first mature T cells, thymic CD4(+)CD25(+) cells were detected as early as 13 weeks of gestation. Thymic CD25(+) cells appeared to be positively selected at the CD4(+)CD8(+)CD3(hi) differentiation stage, as assessed by CD1a and CD69 expression. The proportion of thymic CD4(+)CD25(+) cells appeared quite stable with age, around 6% to 7%, similar to the proportion observed in infant thymi. Extrathymic CD4(+)CD25(+) T cells could hardly be detected at 13 weeks of gestation but were present from week 14 onwards. As adult regulatory T cells, purified CD4(+)CD25(+) fetal cells were anergic and suppressed T-cell proliferative responses; they expressed intracellular cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and Foxp3 mRNA. Altogether, our results indicate that the generation of regulatory/suppressor T cells is consubstantial to the generation of a functional and self-tolerant immune system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731180     DOI: 10.1182/blood-2004-10-4051

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  53 in total

1.  Can maternal microchimeric cells influence the fetal response toward self antigens?

Authors:  Lucie Leveque; Kiarash Khosrotehrani
Journal:  Chimerism       Date:  2011-07-01

2.  Cellular therapies supplement: the peritoneum as an ectopic site of hematopoiesis following in utero transplantation.

Authors:  Marcus O Muench; Jeng-Chang Chen; Ashley I Beyer; Marina E Fomin
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

Review 3.  Human gene therapy and imaging in neurological diseases.

Authors:  Andreas H Jacobs; Alexandra Winkler; Maria G Castro; Pedro Lowenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

4.  Heterogeneity in the CD4 T Cell Compartment and the Variability of Neonatal Immune Responsiveness.

Authors:  Becky Adkins
Journal:  Curr Immunol Rev       Date:  2007-08

5.  A discussion of immune tolerance and the layered immune system hypothesis.

Authors:  Jeff E Mold; Colin C Anderson
Journal:  Chimerism       Date:  2013-05-03

6.  At the crossroads between tolerance and aggression: Revisiting the "layered immune system" hypothesis.

Authors:  Jeff E Mold; Joseph M McCune
Journal:  Chimerism       Date:  2011-04

Review 7.  Fetal regulatory T cells and peripheral immune tolerance in utero: implications for development and disease.

Authors:  Trevor D Burt
Journal:  Am J Reprod Immunol       Date:  2013-02-25       Impact factor: 3.886

8.  Profound loss of intestinal Tregs in acutely SIV-infected neonatal macaques.

Authors:  Xiaolei Wang; Huanbin Xu; Chanjuan Shen; Xavier Alvarez; David Liu; Bapi Pahar; Marion S Ratterree; Lara A Doyle-Meyers; Andrew A Lackner; Ronald S Veazey
Journal:  J Leukoc Biol       Date:  2014-12-09       Impact factor: 4.962

9.  Immunological ignorance allows long-term gene expression after perinatal recombinant adeno-associated virus-mediated gene transfer to murine airways.

Authors:  Marianne S Carlon; Dragana Vidović; James Dooley; Marina Mori da Cunha; Michael Maris; Youlia Lampi; Jaan Toelen; Chris Van den Haute; Veerle Baekelandt; Jan Deprest; Erik Verbeken; Adrian Liston; Rik Gijsbers; Zeger Debyser
Journal:  Hum Gene Ther       Date:  2014-03-26       Impact factor: 5.695

Review 10.  Re-entry of mature T cells to the thymus: an epiphenomenon?

Authors:  Jonathan Sprent; Charles D Surh
Journal:  Immunol Cell Biol       Date:  2008-12-02       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.